Success Metrics

Clinical Success Rate
93.8%

Based on 120 completed trials

Completion Rate
94%(120/128)
Active Trials
45(18%)
Results Posted
20%(24 trials)
Terminated
8(3%)

Phase Distribution

Ph phase_4
19
8%
Ph not_applicable
143
58%
Ph phase_1
23
9%
Ph phase_2
27
11%
Ph early_phase_1
2
1%
Ph phase_3
22
9%

Phase Distribution

25

Early Stage

27

Mid Stage

41

Late Stage

Phase Distribution236 total trials
Early Phase 1First-in-human
2(0.8%)
Phase 1Safety & dosage
23(9.7%)
Phase 2Efficacy & side effects
27(11.4%)
Phase 3Large-scale testing
22(9.3%)
Phase 4Post-market surveillance
19(8.1%)
N/ANon-phased studies
143(60.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

120 of 136 finished

Non-Completion Rate

11.8%

16 ended early

Currently Active

45

trials recruiting

Total Trials

247

all time

Status Distribution
Active(63)
Completed(120)
Terminated(16)
Other(48)

Detailed Status

Completed120
unknown48
Recruiting36
Not yet recruiting14
Active, not recruiting9
Terminated8

Development Timeline

Analytics

Development Status

Total Trials
247
Active
45
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (0.8%)
Phase 123 (9.7%)
Phase 227 (11.4%)
Phase 322 (9.3%)
Phase 419 (8.1%)
N/A143 (60.6%)

Trials by Status

enrolling_by_invitation42%
not_yet_recruiting146%
terminated83%
completed12049%
unknown4819%
recruiting3615%
active_not_recruiting94%
withdrawn83%

Recent Activity

Clinical Trials (247)

Showing 20 of 247 trialsScroll for more
NCT07203911Not Applicable

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

Recruiting
NCT07530952Not Applicable

Green VR for Depression

Completed
NCT06432998Not Applicable

Perineal Massage in Women With Gynecological Cancer

Completed
NCT07540026Not Applicable

Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled Trial

Recruiting
NCT02729974Not Applicable

Use of ROTEM Intraoperatively in Women With Placenta Accreta

Completed
NCT03439267Not Applicable

Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

Active Not Recruiting
NCT06065046Phase 2

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Recruiting
NCT04920032Phase 1

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Recruiting
NCT07505667Not Applicable

Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss

Recruiting
NCT07503301Not Applicable

Small Vessel Disease and Cerebral Infarct Healing InErvation Via Limb Distant Adaptation

Enrolling By Invitation
NCT04291196Not Applicable

Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT

Active Not Recruiting
NCT07035249Phase 1

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

Recruiting
NCT02679768Not Applicable

Electronic Self-monitoring on Regulation of the Sleep-wake Cycle to Reduce Relapse of Depression After Discharge

Completed
NCT07426614Not Applicable

McKenzie Exercises Along With Neurodynamic Mobilization Exercises in Patients With Cervical Radiculopathy

Completed
NCT03683329Phase 3

Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock

Completed
NCT03755362Not Applicable

Dental Carotid Cognitive Study

Terminated
NCT07201519Phase 2

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Recruiting
NCT05032521Phase 4

Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study)

Completed
NCT02492607Not Applicable

Management of Low-risk (Grade I and II) DCIS

Active Not Recruiting
NCT05577741Not Applicable

Effect of the Enriched Environment on the Risk of Relapse

Completed

Drug Details

Intervention Type
OTHER
Total Trials
247